Physician profile
Jessica Turner
NPI 1710663703
$1,518.13
in general payments reported to CMS, 2019-2025
13 companies · $1,358 in 2025
The $1,358 reported for 2025 was more than what 91% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $160 · 2025: $1,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,181 · Travel and Lodging: $337.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,181.48 |
| Travel and Lodging | $336.65 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $437.12 | 2025 | Proclaim, Eterna |
| Abbvie INC. | $276.25 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $273.05 | 2024-2025 | Iovera, Zilretta |
| Averitas Pharma INC. | $125.05 | 2024-2025 | Qutenza |
| Azurity Pharmaceuticals, INC. | $91.43 | 2024-2025 | Horizant, Alvesco |
| Lundbeck LLC | $79.35 | 2024-2025 | Vyepti |
| Spr Therapeutics, INC | $63.82 | 2025 | Sprint Pns System |
| Vertex Pharmaceuticals Incorporated | $51.55 | 2025 | |
| Globus Medical, INC. | $29.37 | 2025 | Senza |
| Axsome Therapeutics, INC. | $26.94 | 2025 | Symbravo |
| Pfizer INC. | $25.54 | 2024 | |
| Fidia Pharma USA INC. | $22.27 | 2025 | Triluron, Hymovis |
| Boston Scientific Corporation | $16.39 | 2025 | Axonics |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jessica Turner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.